EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

BDH2 Inhibits Lung Adenocarcinoma Metastasis by Promoting Ferroptosis

Qiao Yang, Lin Tian, Xiaodong Chen, Xiong Mei, Yongli Nie, Jun Chen

Archivum Immunologiae et Therapiae Experimentalis · 01.01.2026 · 74 (1)

DOI: 10.2478/aite-2026-0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, online erschienen am 09.04.2026. Verfasst von Qiao Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Sinopharm Han Jiang Hospital, Shiyan City, Hubei Province, 442700, China. Hauptthemen laut MEDLINE: Ferroptosis, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate the role of 3-hydroxybutyrate dehydrogenase 2 (BDH2) in regulating ferroptosis and its impact on the metastasis of lung adenocarcinoma (LUAD). Expression levels of BDH2 were modulated in LUAD cell lines (A549, PC9) using pcDNA-BDH2 plasmid transfection. Cell motility was assessed by Transwell assays, while ferroptosis-associated markers, including Fe 2+ , malondialdehyde (MDA), lipid reactive oxygen species (ROS), ACSL4, and GPX4, were evaluated by biochemical assays, flow cytometry, and Western blotting. The involvement of the Nrf2/HO-1 signaling axis was analyzed by Western blotting and RT-qPCR. Furthermore, a xenograft mouse model was established to confirm the effect of BDH2 on tumor progression and metastasis in vivo . Overexpression of BDH2 significantly inhibited LUAD cell migration and invasion. BDH2 upregulation enhanced ferroptosis, effects that were reversed by the ferroptosis inhibitor Fer-1. Mechanistically, BDH2 suppressed the activation of the Nrf2/HO-1 pathway, thereby enhancing sensitivity to ferroptosis. In vivo , BDH2 overexpression markedly reduced tumor growth and metastasis in nude mice, while inhibition of ferroptosis attenuated these effects. BDH2 suppresses metastasis in LAUD by promoting ferroptosis via suppression of the Nrf2/HO-1 pathway, highlighting BDH2 as a potential therapeutic target for LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisLung NeoplasmsAdenocarcinoma of LungHumansAnimalsNF-E2-Related Factor 2MiceCell Line, TumorCell MovementSignal TransductionHeme Oxygenase-1Mice, NudeNeoplasm MetastasisGene Expression Regulation, NeoplasticReactive Oxygen Species

Stichwörter der Autor:innen

BDH2Nrf2/HO-1 signalingSLC7A11ferroptosislung adenocarcinomametastasis

Substanzen

NF-E2-Related Factor 2Heme Oxygenase-1NFE2L2 protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Oncology, Sinopharm Han Jiang Hospital, Shiyan City, Hubei Province, 442700, China.
  • Department of Medicine, Wuhan Wuchang Hospital, Wuhan, Hubei Province, 430063, China.
  • Experimental Center, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, 442008, China.

Zitieren

APA

Yang, Q., Tian, L., Chen, X., Mei, X., Nie, Y., & Chen, J. (2026). BDH2 Inhibits Lung Adenocarcinoma Metastasis by Promoting Ferroptosis. Archivum Immunologiae et Therapiae Experimentalis, 74(1). https://doi.org/10.2478/aite-2026-0012

Vancouver

Yang Q, Tian L, Chen X, Mei X, Nie Y, Chen J. BDH2 Inhibits Lung Adenocarcinoma Metastasis by Promoting Ferroptosis. Archivum Immunologiae et Therapiae Experimentalis. 2026;74(1). doi:10.2478/aite-2026-0012

BibTeX
@article{Yang2026,
  author = {Yang, Qiao and Tian, Lin and Chen, Xiaodong and Mei, Xiong and Nie, Yongli and Chen, Jun},
  title = {BDH2 Inhibits Lung Adenocarcinoma Metastasis by Promoting Ferroptosis},
  journal = {Archivum Immunologiae et Therapiae Experimentalis},
  year = {2026},
  volume = {74},
  number = {1},
  doi = {10.2478/aite-2026-0012}
}
Kostenlos starten →